TUESDAY, Dec. 30, 2025 (HealthDay News) -- For patients with stage III or IV oropharyngeal cancer, intensity-modulated proton therapy (IMPT) is noninferior to intensity-modulated radiation therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback